Nutlin, a small molecule antagonist of MDM2, was found to activate p53 transcription, and mRNA expression of SAT1 was found to be significantly upregulated after using Nutlin on wild-type p53 melanoma cell line A375 [115]. This evidence concerns the gene TP53 and melanoma.